Detection of D2-40 monoclonal antibody-labeled lymphatic vessel invasion in esophageal squamous cell carcinoma and its clinicopathologic significance.

Abstract

OBJECTIVE:

This study aims to investigate the clinicopathologic significance of lymphatic vessel invasion (LVI) labeled by D2-40 monoclonal antibody in esophageal squamous cell carcinoma (ESCC).

METHODS:

Immunohistochemical assay was used to detect the expression of D2-40 and LVI in 107 ESCC patients. Then, the correlation between the clinicopathologic feature and the overall survival time of the patients was analyzed.

RESULTS:

The lymph node metastasis rates were 70% and 21% in the LVI-positive and LVI-negative groups, respectively. The nodal metastasis rate was higher in the LVI-positive group than in the LVI-negative group. Multivariate regression analysis showed that LVI was related to nodal metastasis (P<0.001). The median survival time of the patients was 26 and 43 months in the LVI-positive and LVI-negative groups, respectively. Although univariate regression analysis showed significant difference between the two groups (P=0.014), multivariate regression analysis revealed that LVI was not an independent prognostic factor for overall survival in the ESCC patients (P=0.062). Lymphatic node metastasis (P=0.031), clinical stage (P=0.019), and residual tumor (P=0.026) were the independent prognostic factors.

CONCLUSION:

LVI labeled by D2-40 monoclonal antibody is a risk factor predictive of lymph node metastasis in ESCC patients.

• Authors: Bing Bai, Wei Ma, Kai Wang, Sita Ha, Jian-Bo Wang, Bing-Xu Tan, Na-Na Wang, Sheng-Si Yang, Yi-Bin Jia, Yu-Feng Cheng
• Journal: Cancer biology & medicine (Cancer Biol Med) Vol. 10 Issue 2 Pg. 81-5 (Jun 2013) ISSN: 2095-3941 [Print] China
• PMID: 23882422 (Publication Type: Journal Article)